Loading...
Portfolio Diversification
Range
Most Diversified
20 instruments
January 1, 2022
Least Diversified
0 instruments
February 2, 2025
Average
19.3 instruments
Most Consistent Holdings
Top 5
PFE99.02%
NVAX99.02%
BNTX99.02%
VIR99.02%
MRNA98.96%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Merck (MRK) | 6.27% | 5.65% | 98.84% | - |
 Vaxcyte (PCVX) | 6.17% | 5.6% | 98.71% | - |
| Novavax (NVAX) | 5.78% | 4.61% | 99.02% | - |
| Moderna (MRNA) | 5.68% | 7.63% | 98.96% | - |
 Johnson & Johnson (JNJ) | 5.6% | 5.52% | 98.59% | - |
 Arcturus Therapeutics (ARCT) | 5.31% | 0% | 87.87% | 1/13/2026 |
 Sanofi (SNY) | 5.02% | 3.1% | 98.65% | - |
| BioNTech SE (BNTX) | 5.01% | 4.8% | 99.02% | - |
 Dynavax (DVAX) | 4.86% | 0% | 89.71% | 2/12/2026 |
| Vir (VIR) | 4.86% | 6.59% | 99.02% | - |
| Pfizer (PFE) | 4.52% | 3.75% | 99.02% | - |
 Abbott (ABT.US) | 4.23% | 3.6% | 77.76% | - |
 AstraZeneca (AZN) | 3.95% | 3.2% | 77.51% | - |
 CureVac (CVAC) | 3.75% | 0% | 87.44% | 1/13/2026 |
 Maravai (MRVI) | 2.48% | 6.32% | 56.31% | - |
 Agenus (AGEN) | 2.47% | 0% | 65.26% | 1/2/2025 |
 Valneva (VLA.PA) | 2.42% | 1.83% | 56.62% | - |
 Emergent BioSolutions (EBS) | 2.36% | 0% | 64.89% | 1/13/2026 |
 GlaxoSmithKline (GSK) | 2.15% | 0% | 42.4% | 12/28/2023 |
 Vaxart (VXRT) | 1.82% | 0% | 43.87% | 1/13/2026 |
 ImmunityBio (IBRX) | 1.61% | 14.63% | 10.85% | - |
 Personalis (PSNL) | 1.59% | 6.34% | 33.27% | - |
 Inovio (INO) | 1.57% | 2.87% | 53.49% | - |
 OPKO Health (OPK) | 1.12% | 2.99% | 33.7% | - |
 Bavarian Nordic A/S (BAVA.CO) | 1.08% | 0% | 22.43% | 1/13/2026 |
 CanSino Biologics (6185.HK) | 1.07% | 0% | 22.79% | 1/2/2025 |
 CSL (CSL.ASX) | 0.88% | 0% | 22.49% | 1/1/2025 |
 Takeda (TAK) | 0.81% | 0% | 21.45% | 12/28/2023 |
 Allovir (KLRS) | 0.63% | 0% | 21.26% | 1/5/2023 |
 Invivyd (IVVD) | 0.6% | 0% | 20.96% | 1/5/2023 |
 VBI Vaccines (VBIVQ) | 0.55% | 0% | 21.26% | 1/5/2023 |
 Zoetis (ZTS) | 0.45% | 2.85% | 10.97% | - |
 GSK (GSK.L) | 0.01% | 0% | 0.31% | 1/5/2022 |
 Sanofi (SAN.PA) | 0.01% | 0% | 0.31% | 1/5/2022 |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Johnson & Johnson (JNJ) | 4.88% | 8.07% |
| Valneva (VLA.PA) | 4.65% | 6.84% |
| Dynavax (DVAX) | 3.77% | 6.62% |
| AstraZeneca (AZN) | 3.6% | 6.59% |
| Merck (MRK) | 3.45% | 6.29% |
| Personalis (PSNL) | 3.5% | 6.22% |
| Abbott (ABT.US) | 3.44% | 5.37% |
| CureVac (CVAC) | 9.61% | 5.29% |
| BioNTech SE (BNTX) | 7.82% | 5.27% |
| Emergent BioSolutions (EBS) | 2.95% | 5.09% |
| Bavarian Nordic A/S (BAVA.CO) | 3.4% | 4.48% |
| Novavax (NVAX) | 5.04% | 4.47% |
| Pfizer (PFE) | 6.17% | 4.22% |
| Sanofi (SNY) | 3.1% | 4.15% |
| Moderna (MRNA) | 10.67% | 3.93% |
| Vaxcyte (PCVX) | 1.4% | 3.62% |
| Vir (VIR) | 7.44% | 3.23% |
| Maravai (MRVI) | 4.61% | 3.16% |
| Arcturus Therapeutics (ARCT) | 5.94% | 2.26% |
| Vaxart (VXRT) | 3.23% | 2.06% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.